Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Assessment of medical students' leadership traits in a problem/case-based learning program.

Ginzburg SB, Schwartz J, Gerber R, Deutsch S, Elkowitz DE, Ventura-Dipersia C, Lim YS, Lucito R.

Med Educ Online. 2018 Dec;23(1):1542923. doi: 10.1080/10872981.2018.1542923. Epub 2018 Nov 8.

PMID:
30406727
2.

Integration of leadership training into a problem/case-based learning program for first- and second-year medical students.

Ginzburg SB, Deutsch S, Bellissimo J, Elkowitz DE, Stern JN, Lucito R.

Adv Med Educ Pract. 2018 Apr 9;9:221-226. doi: 10.2147/AMEP.S155731. eCollection 2018.

3.

Reciprocal interaction of Wnt and RXR-α pathways in hepatocyte development and hepatocellular carcinoma.

Li J, Chanrion M, Sawey E, Wang T, Chow E, Tward A, Su Y, Xue W, Lucito R, Zender L, Lowe SW, Bishop JM, Powers S.

PLoS One. 2015 Mar 4;10(3):e0118480. doi: 10.1371/journal.pone.0118480. eCollection 2015.

4.

A quantitative proteomics-based signature of platinum sensitivity in ovarian cancer cell lines.

Fan G, Wrzeszczynski KO, Fu C, Su G, Pappin DJ, Lucito R, Tonks NK.

Biochem J. 2015 Feb 1;465(3):433-42. doi: 10.1042/BJ20141087.

5.

Missing-in-Metastasis regulates cell motility and invasion via PTPδ-mediated changes in SRC activity.

Chaudhary F, Lucito R, Tonks NK.

Biochem J. 2015 Jan 1;465(1):89-101. doi: 10.1042/BJ20140573.

6.

Integrative prediction of gene function and platinum-free survival from genomic and epigenetic features in ovarian cancer.

Wrzeszczynski KO, Varadan V, Kamalakaran S, Levine DA, Dimitrova N, Lucito R.

Methods Mol Biol. 2013;1049:35-51. doi: 10.1007/978-1-62703-547-7_4.

PMID:
23913207
7.

Protein-tyrosine phosphatase 1B antagonized signaling by insulin-like growth factor-1 receptor and kinase BRK/PTK6 in ovarian cancer cells.

Fan G, Lin G, Lucito R, Tonks NK.

J Biol Chem. 2013 Aug 23;288(34):24923-34. doi: 10.1074/jbc.M113.482737. Epub 2013 Jun 28.

8.

Two Distinct Categories of Focal Deletions in Cancer Genomes.

Rajaram M, Zhang J, Wang T, Li J, Kuscu C, Qi H, Kato M, Grubor V, Weil RJ, Helland A, Borrenson-Dale AL, Cho KR, Levine DA, Houghton AN, Wolchok JD, Myeroff L, Markowitz SD, Lowe SW, Zhang M, Krasnitz A, Lucito R, Mu D, Powers RS.

PLoS One. 2013 Jun 21;8(6):e66264. doi: 10.1371/journal.pone.0066264. Print 2013.

9.

Loss of DOK2 induces carboplatin resistance in ovarian cancer via suppression of apoptosis.

Lum E, Vigliotti M, Banerjee N, Cutter N, Wrzeszczynski KO, Khan S, Kamalakaran S, Levine DA, Dimitrova N, Lucito R.

Gynecol Oncol. 2013 Aug;130(2):369-76. doi: 10.1016/j.ygyno.2013.05.002. Epub 2013 May 14.

10.

Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer.

Wrzeszczynski KO, Varadan V, Byrnes J, Lum E, Kamalakaran S, Levine DA, Dimitrova N, Zhang MQ, Lucito R.

PLoS One. 2011;6(12):e28503. doi: 10.1371/journal.pone.0028503. Epub 2011 Dec 8.

11.

DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables.

Kamalakaran S, Varadan V, Giercksky Russnes HE, Levy D, Kendall J, Janevski A, Riggs M, Banerjee N, Synnestvedt M, Schlichting E, Kåresen R, Shama Prasada K, Rotti H, Rao R, Rao L, Eric Tang MH, Satyamoorthy K, Lucito R, Wigler M, Dimitrova N, Naume B, Borresen-Dale AL, Hicks JB.

Mol Oncol. 2011 Feb;5(1):77-92. doi: 10.1016/j.molonc.2010.11.002. Epub 2010 Dec 2.

12.

Comparative genomic hybridization by representational oligonucleotide microarray analysis.

Lucito R, Byrnes J.

Methods Mol Biol. 2009;556:33-46. doi: 10.1007/978-1-60327-192-9_4.

PMID:
19488870
13.

Methylation detection oligonucleotide microarray analysis: a high-resolution method for detection of CpG island methylation.

Kamalakaran S, Kendall J, Zhao X, Tang C, Khan S, Ravi K, Auletta T, Riggs M, Wang Y, Helland A, Naume B, Dimitrova N, Børresen-Dale AL, Hicks J, Lucito R.

Nucleic Acids Res. 2009 Jul;37(12):e89. doi: 10.1093/nar/gkp413. Epub 2009 May 27.

14.

Genomic events associated with progression of pleural malignant mesothelioma.

Ivanov SV, Miller J, Lucito R, Tang C, Ivanova AV, Pei J, Carbone M, Cruz C, Beck A, Webb C, Nonaka D, Testa JR, Pass HI.

Int J Cancer. 2009 Feb 1;124(3):589-99. doi: 10.1002/ijc.23949.

15.

Copy number alterations in pancreatic cancer identify recurrent PAK4 amplification.

Chen S, Auletta T, Dovirak O, Hutter C, Kuntz K, El-ftesi S, Kendall J, Han H, Von Hoff DD, Ashfaq R, Maitra A, Iacobuzio-Donahue CA, Hruban RH, Lucito R.

Cancer Biol Ther. 2008 Nov;7(11):1793-802. Epub 2008 Nov 21.

PMID:
18836286
16.

Frequent genomic copy number gain and overexpression of GATA-6 in pancreatic carcinoma.

Fu B, Luo M, Lakkur S, Lucito R, Iacobuzio-Donahue CA.

Cancer Biol Ther. 2008 Oct;7(10):1593-601. Epub 2008 Oct 7.

PMID:
18769116
17.

DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma.

Xue W, Krasnitz A, Lucito R, Sordella R, Vanaelst L, Cordon-Cardo C, Singer S, Kuehnel F, Wigler M, Powers S, Zender L, Lowe SW.

Genes Dev. 2008 Jun 1;22(11):1439-44. doi: 10.1101/gad.1672608.

18.

High-content analysis of cancer genome DNA alterations.

Degenhardt YY, Wooster R, McCombie RW, Lucito R, Powers S.

Curr Opin Genet Dev. 2008 Feb;18(1):68-72. doi: 10.1016/j.gde.2008.01.005. Epub 2008 Mar 12. Review.

19.

Allele-specific marker generation and linkage mapping on the Xiphophorus sex chromosomes.

Woolcock B, Kazianis S, Lucito R, Walter RB, Kallman KD, Morizot DC, Vielkind JR.

Zebrafish. 2006;3(1):23-37. doi: 10.1089/zeb.2006.3.23.

PMID:
18248244
20.

Copy-number variants in patients with a strong family history of pancreatic cancer.

Lucito R, Suresh S, Walter K, Pandey A, Lakshmi B, Krasnitz A, Sebat J, Wigler M, Klein AP, Brune K, Palmisano E, Maitra A, Goggins M, Hruban RH.

Cancer Biol Ther. 2007 Oct;6(10):1592-9. Epub 2007 Jul 12.

PMID:
17912030
21.

Identification of alterations in DNA copy number in host stromal cells during tumor progression.

Pelham RJ, Rodgers L, Hall I, Lucito R, Nguyen KC, Navin N, Hicks J, Mu D, Powers S, Wigler M, Botstein D.

Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19848-53. Epub 2006 Dec 13.

22.

Gene mutations and genomic rearrangements in the mouse as a result of transposon mobilization from chromosomal concatemers.

Geurts AM, Collier LS, Geurts JL, Oseth LL, Bell ML, Mu D, Lucito R, Godbout SA, Green LE, Lowe SW, Hirsch BA, Leinwand LA, Largaespada DA.

PLoS Genet. 2006 Sep 29;2(9):e156. Epub 2006 Aug 3.

23.

Generation and analysis of genetically defined liver carcinomas derived from bipotential liver progenitors.

Zender L, Xue W, Cordón-Cardo C, Hannon GJ, Lucito R, Powers S, Flemming P, Spector MS, Lowe SW.

Cold Spring Harb Symp Quant Biol. 2005;70:251-61.

24.

Mouse genomic representational oligonucleotide microarray analysis: detection of copy number variations in normal and tumor specimens.

Lakshmi B, Hall IM, Egan C, Alexander J, Leotta A, Healy J, Zender L, Spector MS, Xue W, Lowe SW, Wigler M, Lucito R.

Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11234-9. Epub 2006 Jul 14.

25.

Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach.

Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, Silke J, Fan ST, Luk JM, Wigler M, Hannon GJ, Mu D, Lucito R, Powers S, Lowe SW.

Cell. 2006 Jun 30;125(7):1253-67.

26.

Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms' tumor.

Prawitt D, Enklaar T, Gärtner-Rupprecht B, Spangenberg C, Oswald M, Lausch E, Schmidtke P, Reutzel D, Fees S, Lucito R, Korzon M, Brozek I, Limon J, Housman DE, Pelletier J, Zabel B.

Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):4085-90. Epub 2005 Mar 2.

27.

A versatile statistical analysis algorithm to detect genome copy number variation.

Daruwala RS, Rudra A, Ostrer H, Lucito R, Wigler M, Mishra B.

Proc Natl Acad Sci U S A. 2004 Nov 16;101(46):16292-7. Epub 2004 Nov 8.

28.

Circular binary segmentation for the analysis of array-based DNA copy number data.

Olshen AB, Venkatraman ES, Lucito R, Wigler M.

Biostatistics. 2004 Oct;5(4):557-72.

PMID:
15475419
29.

Large-scale copy number polymorphism in the human genome.

Sebat J, Lakshmi B, Troge J, Alexander J, Young J, Lundin P, Månér S, Massa H, Walker M, Chi M, Navin N, Lucito R, Healy J, Hicks J, Ye K, Reiner A, Gilliam TC, Trask B, Patterson N, Zetterberg A, Wigler M.

Science. 2004 Jul 23;305(5683):525-8.

30.

RNA interference microarrays: high-throughput loss-of-function genetics in mammalian cells.

Silva JM, Mizuno H, Brady A, Lucito R, Hannon GJ.

Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6548-52. Epub 2004 Apr 14.

31.

Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation.

Lucito R, Healy J, Alexander J, Reiner A, Esposito D, Chi M, Rodgers L, Brady A, Sebat J, Troge J, West JA, Rostan S, Nguyen KC, Powers S, Ye KQ, Olshen A, Venkatraman E, Norton L, Wigler M.

Genome Res. 2003 Oct;13(10):2291-305. Epub 2003 Sep 15.

32.

Using cDNA-representational difference analysis (cDNA-RDA) in combination with microarrays to identify Rac regulated genes.

Schmitz AA, Lucito R, Van Aelst L.

Methods Mol Biol. 2002;189:25-43. No abstract available.

PMID:
12094592
33.

Detecting gene copy number fluctuations in tumor cells by microarray analysis of genomic representations.

Lucito R, West J, Reiner A, Alexander J, Esposito D, Mishra B, Powers S, Norton L, Wigler M.

Genome Res. 2000 Nov;10(11):1726-36.

34.

Genetic analysis using genomic representations.

Lucito R, Nakimura M, West JA, Han Y, Chin K, Jensen K, McCombie R, Gray JW, Wigler M.

Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4487-92.

35.
39.

Supplemental Content

Loading ...
Support Center